Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new clinical trial conducted in Australia. This growing body of evidence badly undermines regulations that limit adult access to safer nicotine products that could save their lives.

A randomized controlled trial (RCT) evaluated whether vaporized nicotine products (VNPs) are more effective than nicotine replacement therapies (NRT) for smoking cessation among people

“Although current evidence suggests switching completely from cigarette smoking to (vaping) reduces health risks, the long-term health effects of vaping are largely unknown and data are emerging that demonstrate vaping can impact cardiovascular health,” researchers wrote.

The FDA will also need to determine how the newer nicotine delivery systems—including e-cigarettes—will fit within the nicotine replacement therapy regulatory framework, if at all.

The number of young children sickened after getting their hands on nicotine products like pouches and vape e-liquids has skyrocketed in recent years.

The FDA’s proposal does not include e-cigarettes, other vape products, hookahs, smokeless tobacco products or nicotine replacement pouches. “While my preference would be that use of all of ...

The FDA’s proposal does not include e-cigarettes, other vape products, hookahs, smokeless tobacco products or nicotine replacement pouches. “While my preference would be that use of all of ...

FDA moves to slash nicotine in cigarettes The proposed rule would drastically reduce the level of nicotine allowed in combustible tobacco products, but it would not apply to vapes.